Search Within

William Douglas Tap

Formats
  1. Journal Article (191)
  2. Meeting Abstract (159)
  3. Review (10)
  4. Book Section (4)
  5. Editorial (4)
  6. Guidelines (3)
  7. Miscellaneous (2)
  8. Research Letter (1)
Groups
  1. Department of Medicine (374)
  2. Sarcoma Service (374)
  3. Solid Tumor Oncology Division (374)
  4. GSK Faculty (158)
  5. Tow Center for Developmental Oncology (TCDO) (148)
  6. Department of Pathology and Laboratory Medicine (132)

More Groups

People
  1. Sandra D'Angelo (105)
  2. Cristina Antonescu (96)
  3. Mark Dickson (91)
  4. Samuel Singer (80)
  5. Mrinal Gounder (78)
  6. Mary Keohan (76)

More People

Years
  1. 2025 (16)
  2. 2024 (50)
  3. 2023 (34)
  4. 2022 (43)
  5. 2021 (25)
  6. 2020 (34)

More Years

Publications
  1. Journal of Clinical Oncology (102)
  2. Annals of Oncology (30)
  3. Clinical Cancer Research (27)
  4. Cancer Research (14)
  5. Modern Pathology (11)
  6. Lancet Oncology (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (109)
  2. American Association for Cancer Research (48)
  3. Oxford University Press (38)
  4. Elsevier Science, Inc. (22)
  5. Elsevier Inc. (20)
  6. Nature Publishing Group (19)

More Publishers

Results (374)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Results of an open-label, phase Ia/b study of pembrolizumab plus olaratumab in patients with unresectable, locally advanced, or metastatic soft-tissue sarcoma
    Journal Article

    Sch€offski, P.; Bahleda, R.; Wagner, A. J.; Burgess, M. A.; Junker, N.; Chisamore, M.; Peterson, P.; Szpurka, A. M.; Ceccarelli, M.; Tap, W. D.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • SARC041: A phase 3 randomized double-blind study of abemaciclib versus placebo in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    Dickson, M. A.; Ballman, K. V.; Weiss, M. C.; Attia, S.; Wagner, M. J.; Pollack, S.; Choy, E.; Wagner, A. J.; Wilky, B. A.; Davis, L. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    D'Angelo, S. P.; Rosenbaum, E.; Gularte Mérida, R.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 2, open-label, adaptive, dose-ranging study with long-term extension to evaluate the safety, tolerability, efficacy, and pharmacokinetics of intra-articular AMB-05X injections in patients with tenosynovial giant cell tumor
    Meeting Abstract

    Gelderblom, H.; Bhadri, V.; Randall, R. L.; Scharschmidt, T.; Tap, W. D.; Alani, L.; Johnson, K.; Leyva, S.; Nguyen, D. D.; Nguyen, T.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Survivorship in patients with cardiac metastases defined by cardiac magnetic resonance imaging in relation to lesion hypoperfusion
    Meeting Abstract

    Jain, R.; Liberman, N.; Agoglia, H.; Park, M.; Park, R.; Jessurun, J.; Tap, W. D.; Kim, J.; Steingart, R.; Liu, J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Initial results from the phase (ph) 1 portion of a ph 1/2 study of THE-630 in patients (pts) with advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    George, S.; Tap, W. D.; von Mehren, M.; Gordon, M. S.; Trent, J. C.; Attia, S.; Zhang, S.; Narasimhan, N.; Rivera, V. M.; Kerstein, D.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Real-world utilization pattern of pexidartinib in patients with tenosynovial giant cell tumor (TGCT)
    Meeting Abstract

    Lin, F.; Tse, J.; Shaikh, N. F.; Wang, E. J.; Near, A.; Kwong, J.; Tap, W. D.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase I study of the mutant IDH1 inhibitor ivosidenib: Long-term safety and clinical activity in patients with conventional chondrosarcoma
    Meeting Abstract

    Tap, William D.; Cote, Gregory Michael; Burris, Howard A.; Gore, Lia; Beeram, Muralidhar; Conley, Anthony Paul; Gianolio, Diego A.; Qu, Zhe; Gliser, Camelia; Pandya, Shuchi Sumant; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Safety, pharmacokinetics (PK), and clinical activity of bezuclastinib + sunitinib in previously-treated gastrointestinal stromal tumor (GIST): Results from part 1 of the phase 3 Peak study
    Meeting Abstract

    Tap, W. D.; Wagner, A. J.; Bauer, S.; Heinrich, M. C.; Jones, R. L.; Serrano, C.; von Mehren, M.; Somaiah, N.; Andor, T.; Zou, L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save